General Electric News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

26.11.12	GE Healthcare Revolutionizes the MR Patient Scanning Experience with Silent Scan (Businesswire)
25.11.12	New LOGIQ E9 with XDclear from GE Healthcare Boosts Image Quality and Enhances Diagnostic Confidence (Businesswire)
15.11.12	GE Healthcare scientist paired with Cardiff MP to share insights on cell therapy, science and policy-making (Businesswire)
07.11.12	Von GE Healthcare vorgenommene frühe wirtschaftliche Auswertung unterstreicht potenzielle Vorteile einer biomarkerorientierten Behandlung bei Brustkrebs und Nierenzellkarzinom (Businesswire)
07.11.12	Early Economic Evaluation from GE Healthcare Highlights the Potential Benefits of Biomarker-Directed Care in Breast Cancer and Renal Cell Carcinoma (Businesswire)
18.10.12	GE Healthcare verbindet Menschen durch Musik und bekämpft Brustkrebs mit der ersten von Spotify unterstützten Gesundheitsinitiative (Businesswire)
18.10.12	GE Healthcare Connects People through Music in Fight Against Breast Cancer with First Health Initiative powered by Spotify (Businesswire)
02.10.12	GE Healthcare kündigt "GE Global Pink Ribbons"-Initiative an, um den Breast Cancer Awareness Month sichtbar zu machen (Businesswire)
01.10.12	GE Healthcare Mobilizes 'GE Global Pink Ribbons' to Support Breast Cancer Awareness Month (Businesswire)
12.09.12	Phase-III-Ergebnisse für das Prüfkontrastmittel [18F]Flutemetamol belegen dessen Fähigkeit, Beta-Amyloid bei lebenden Patienten sicher nachzuweisen (Businesswire)
11.09.12	Phase III Results for Investigational Imaging Agent [18F]Flutemetamol Demonstrate Ability to Accurately Detect Beta Amyloid in Living Patients (Businesswire)
04.09.12	GE Healthcare führt modulare biopharmazeutische Anlage KUBio ein (Businesswire)
04.09.12	GE Healthcare Launches Modular Biopharmaceutical Factory, KUBio (Businesswire)
20.08.12	GE Healthcare startet Kampagne zu Krebsbewusstsein und -prävention, unterstützt durch soziale Netzwerke (Businesswire)
20.08.12	GE Healthcare Launches Social Media Driven Cancer Awareness and Prevention Campaign (Businesswire)
26.07.12	GE Healthcare präsentiert exklusiven virtuellen 360-Grad-Rundgang durch die Olympische Poliklinik in London 2012 (Businesswire)
26.07.12	GE Healthcare Unveils an Exclusive 360 Degree Virtual Video Tour of London 2012 Olympic Village Polyclinic (Businesswire)
18.07.12	Introducing the Innovative, Energy Efficient, Full LED 2012 Lineup of GE Side-By-Side Refrigerators (Businesswire)
18.07.12	Einführung des innovativen, energieeffizienten, Voll-LED-2012-Produktprogrammes von GE Side-By-Side Kühlschränken (Businesswire)
17.07.12	Final Phase 3 Results for GE Healthcare Investigational Imaging Agent Flutemetamol Presented at Alzheimer’s Association International Conference® (Businesswire)
21.06.12	DaTSCAN™ (Loflupan I 123 Injektion) SPECT-Bildgebung unterstützt Diagnose und Behandlung von Patienten mit klinisch unklarem Parkinson-Syndrom (Businesswire)
20.06.12	Saint Luke’s Neuroscience Institute’s Stroke Program Found to Substantially Improve Access to Care and Drive Better Patient Outcomes (Businesswire)
20.06.12	DaTSCAN™ (Ioflupane I 123 Injection) SPECT Imaging Impacts the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome (Businesswire)
12.06.12	New Data Presented at the Society for Nuclear Medicine Annual Meeting Supports Efficacy Profile of Imaging Agent [18F]Flutemetamol for Detection of Amyloid Plaque Linked to Alzheimer’s Disease (Businesswire)
11.06.12	GE Healthcare Furthers Research and Development Efforts in Alzheimer’s Disease with Australian Government Partnership (Businesswire)
07.06.12	GE Healthcare and Affibody AB to Collaborate on Her2 specific PET Imaging Agent for Breast and Gastric Cancer (Businesswire)
07.06.12	Zusammenarbeit von GE Healthcare und Affibody AB bei der Entwicklung eines Her2-spezifischen PET-Bildgebungsmittels für Brust- und Magenkrebs (Businesswire)
04.06.12	Early Economic Evaluation Highlights the Potential Benefits of Biomarkers to Guide Usage of Anti-angiogenic Therapy for Metastatic Colorectal Cancer Patients (Businesswire)
02.06.12	GE Healthcare and Affibody AB to Collaborate on Her2 specific PET Imaging Agent for Breast and Gastric Cancer (Businesswire)
02.06.12	Use of Mammostrat Bioassay Predicts Early Relapse Risk in ER-Positive Postmenopausal Breast Cancer Patients (Businesswire)
31.05.12	GE Healthcare Licenses Genomic Biomarker for Lung Cancer from Insight Genetics (Businesswire)
30.05.12	GE Healthcare to Showcase Innovative Breast Cancer Solutions from Screening through Monitoring at ASCO 2012 (Businesswire)
22.05.12	Karolinska University Hospital and GE Healthcare Collaborate to Advance Technologies for Cell Therapy (Businesswire)
10.05.12	GE Healthcare Life Sciences Completes Acquisition of Xcellerex, Inc. (Businesswire)
10.05.12	GE Healthcare Life Sciences bringt Akquisition von Xcellerex, Inc. zum Abschluss (Businesswire)
08.05.12	GE Healthcare Secures Additional Supply of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) (Businesswire)
24.04.12	GE Healthcare: DaTscan™ (Ioflupane I 123 Injection) SPECT Imaging Demonstrates Impact on the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome (Businesswire)
13.04.12	GE Healthcare intensiviert FuE-Aktivitäten im Bereich Alzheimer (Businesswire)
13.04.12	GE Healthcare Strengthens R&D Efforts in Alzheimer’s Disease (Businesswire)
11.04.12	GE Healthcare Announces Preliminary Phase 3 Results for Flutemetamol (Businesswire)
21.03.12	GE Healthcare Expands Shanghai Fast Trak Training Center to Serve Growing Biopharmaceutical Industry in China (Businesswire)
07.03.12	GE Healthcare steht vor Übernahme von Xcellerex Inc. und erweitert damit Kompetenzen in aufstrebender Sparte der biopharmazeutischen Produktion (Businesswire)
06.03.12	GE Aviation Signs Agreement with GeoEye for 3D Airport Maps and High-Resolution Earth Imagery (Businesswire)
06.03.12	GE unterstützt Flugsicherungsanbieter rund um den Globus mit anpassbaren leistungsorientierten Navigationslösungen (Businesswire)
06.03.12	GE Aviation unterzeichnet Vertrag mit GeoEye über die Bereitstellung dreidimensionaler Flughafenkarten und hochauflösender Satellitenbilder (Businesswire)
06.03.12	GE Supports Air Navigation Service Providers Around the World with Customizable Performance-based Navigation Solutions (Businesswire)
05.03.12	Contrast Media and CT Image Reconstruction from GE Healthcare Medical Diagnostics Set New Standard for Quality Imaging and Patient Care (Businesswire)
27.02.12	Bay Ridge Medical Imaging, PC First to Offer GE 3.0T Wide Bore MRI in U.S. (Businesswire)
20.02.12	GE Healthcare offers Fast Trak Training in Singapore to serve growing South East Asian biopharmaceutical industry (Businesswire)
30.01.12	Capital Health Will be First in U.S. to Offer GE Molecular Breast Imaging (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

29.11.24		Pluszeichen in New York: Letztendlich Gewinne im Dow Jones
29.11.24		Starker Wochentag in New York: Dow Jones mit Kursplus
29.11.24		Gewinne in Europa: Euro STOXX 50 präsentiert sich zum Ende des Freitagshandels fester
29.11.24		Starker Wochentag in Frankfurt: TecDAX zum Handelsende mit Zuschlägen
29.11.24		DAX-Handel aktuell: DAX legt zum Handelsende zu
29.11.24		Börse Europa: Anleger lassen STOXX 50 zum Handelsende steigen
29.11.24		XETRA-Handel: LUS-DAX schlussendlich mit Zuschlägen